MRI Masterclass in Prostate Cancer for Urologists

  • 18 hours
  • 2 days


Learn everything you need to know about prostate MRI for the diagnosis and management of patients with prostate cancer on this two-day course for urologists (trainees and consultants).

The prostate cancer-management pathway is moving towards image-guided diagnosis and treatment. This course will provide interactive teaching from a world-renowned faculty in prostate MRI interpretation.

It will equip urologists to be able to use MRI in the management of patients with prostate cancer and run an image-guided service.

You'll gain 12 CPD points.

This short course is run by staff at UCL and UCLH (University College London Hospital). It's accredited by the British Association of Urological Surgeons.

Course content

The course will cover the following:

  • The importance of prostate MRI to the urologist
  • Recognising prostate anatomy on MRI
  • Identifying areas suspicious for prostate cancer on multi-parametric MRI
  • How to use MRI to help guide management decisions in prostate cancer patients
  • Contouring the prostate on MRI prior to MRI-targeted biopsy and treatments
  • Using MRI imaging to guide prostate biopsy

Who this course is for

You'll need to be a urological consultant or trainee with an interest in prostate cancer.

Course structure and teaching

The course runs over two days, with the following learning format:

  • Hands-on MRI interpretation workshop with expert faculty using real prostate MRIs
  • You'll be given a Mac with OSIRIX software for viewing MRI scans and will have significant time to interpret new scans with individual feedback on performance
  • Hands-on demonstration of image-fusion software in MRI-targeted prostate biopsy
  • Lectures and case-based discussions to demonstrate the role of MRI in the diagnosis and treatment of men with prostate cancer

CPD accreditation and certificates

You'll be assessed at baseline and at the end of the course in the interpretation of prostate MRI images to demonstrate what you've learnt. You'll receive a breakdown of your performance by email following the course.

You'll gain 12 CPD points (accredited by the British Association of Urological Surgeons) and will receive a certificate of attendance.

Learning outcomes

By the end of the course you should be able to:

  • understand the importance of MRI interpretation for the practicing urologist
  • recognise prostate anatomy on MRI
  • identify areas suspicious for prostate cancer on multi-parametric MRI
  • understand the limitations of prostate MRI
  • use MRI to help guide management decisions in prostate cancer patients
  • contour the prostate on MRI prior to MRI-targeted biopsy and treatments

How you and your employer will benefit

UCL and UCLH are at the international forefront of prostate MRI research and use in clinical practice. Over 1000 MRI scans are performed at UCLH every year. UCL researchers have played a key role in the development and evaluation of this technology in clinical practice. The faculty comprise some of these key researchers and clinicians.

You'll also:

  • benefit from networking opportunities with faculty
  • have the opportunity to get involved in research in MRI-targeted biopsy
  • be able to launch your own image-guided diagnostic services at your own trusts

Sign up for short course announcements: Subscribe to the UCL Life Learning newsletter to receive news and updates on courses in your chosen area. (For updates on a specific course, contact the administrator - see 'Contact information'.)

Course team

Dr Clare Allen

Clare qualified from Oxford University and is Consultant Radiologist at UCL with an academic interest in uro-oncology, in particular prostate MR-imaging. She has a well-developed clinical practice in dynamic contrast-enhanced MR in the prostate and is leading a team of medical physicists in further defining the role of multi-sequence MRI in diagnostic utility of prostate cancer.

Professor Mark Emberton

Mark is Dean of UCL Faculty of Medical Sciences and Honorary Consultant Urologist at UCL. Leading an internationally recognised research group which looks at better diagnosis and treatment for men with prostate cancer, he is a major grant holder, a frequent speaker at international meetings and has published over 250 peer-reviewed scientific papers. He is chief investigator on a number of MRI-based diagnostic and interventional studies and has been elected as a Fellow of the Academy of Medical Sciences.

Veeru Kasivisvanathan

Veeru is an NIHR Doctoral Fellow and Specialist Registrar in Urology. He is completing a PhD evaluating the the role of MRI-targeted biopsies in the diagnosis of prostate cancer and is coordinating an international multi-centre randomised controlled trial, PRECISION (NCT02380027), as part of this. He's part of the team that runs the diagnostic MRI-targeted biopsy service at UCLH and is responsible for the multi-disciplinary team management of these patients.

Dr Alex Kirkham

Alex is Consultant Radiologist at UCLH, specialising in urological radiology. He has both a clinical and a research interest in prostate cancer imaging, in particular MRI for the detection of tumour and the assessment of ablative therapies.

Caroline Moore

Caroline Moore is Senior Lecturer at UCL and Honorary Consultant Urological Surgeon at UCLHl. She's an active clinical researcher and has published in the areas of MRI-targeted prostate biopsy, active surveillance and focal therapy for prostate cancer. She's involved in numerous international collaborations in prostate cancer diagnosis, active surveillance and focal therapy.

Dr Shonit Punwani

Shonit is Consultant Radiologist at UCLH, and Reader in Magnetic Resonance and Cancer Imaging at UCL. He has an additional postgraduate qualification in MRI physics and is responsible for the 3T MR research facility at UCLH, which is developing novel MRI techniques for first-in-man oncological imaging studies. He has a specialist clinical and research interest in the application and development of quantitative functional MRI for the detection and monitoring of prostate cancer and its treatments.

Course information last modified: 29 Aug 2018, 11:17